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Introduction {#sec005}
============

Infertility has been acknowledged as a very common health problem that affects approximately 15%-20% of couples who want to conceive \[[@pone.0121147.ref001]\], and almost 50% cases are because of male factors. Despite significant advancements in the male infertility diagnoses, the etiology remains unknown in almost half of all male infertile cases \[[@pone.0121147.ref002]\]. However, spermatogenic failure is the most common phenomenon among these cases. At present, it has been postulated that genetic abnormalities are thought to account for 15%-30% of male factor infertility, which include Y chromosome microdeletions, translocation, chromosomal aberrations and single-gene mutations \[[@pone.0121147.ref003]--[@pone.0121147.ref006]\]. In many infertile men, deleterious gene polymorphisms in key genes involved in testicular function, combined with environmental factors, may be responsible for the poor quality and number reduction of the sperm.

Folate is very important for the maintenance of genome integrity due to its role in DNA synthesis, repair and methylation \[[@pone.0121147.ref007], [@pone.0121147.ref008]\]. It is known that folate deficiency occur frequently, and the related hyperhomocysteinaemia is considered as a risk factor for various diseases, including infertility. Methylenetetrahydrofolate reductase (*MTHFR*) is one of the key regulatory enzymes in folate metabolism which can catalyze the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the methyl donor for homocysteine in the synthesis of methionine. Subsequently, methionine in its activated form S-adenosylmethionine is the methyl donor for DNA methylation \[[@pone.0121147.ref009]\]. Methylation anomalies of sperm DNA has been linked to male infertility \[[@pone.0121147.ref010]\]. Moreover, it has been reported that the folate metabolic pathways can be modified by polymorphisms of relevant genes such as *MTHFR* or by the action of carcinogenic elements, for example, alcohol or tobacco \[[@pone.0121147.ref011]\].

The *MTHFR* gene, located on the short arm of chromosome1 (1p36.3), which is composed of 11 exons \[[@pone.0121147.ref012], [@pone.0121147.ref013]\]. The change of C for T at the nucleotide position 677 of the *MTHFR* gene causes the substitution of valine for alanine in the *MTHFR* protein and a consequent reduction in enzyme activity. The *MTHFR* 677C\>T variant decreases the activity of the enzyme by 35% in the presence of heterozygosis and by 70% in homozygosis \[[@pone.0121147.ref012]\]. Reduced enzymatic activity due to *MTHFR* polymorphisms is considered as a risk factor for many diseases, including infertility \[[@pone.0121147.ref014]\].

Recent years, a number of epidemiological studies have been conducted to examine the association between *MTHFR* 677C\>T polymorphism and male infertility risk in diverse populations, but the results of these studies remain conflicting rather than conclusive. Some studies exhibited significantly increased risk of male infertility with *MTHFR* 677C\>T, while some other studies showed nonsignificantly enhanced risk. As a result, there were five meta-analyses \[[@pone.0121147.ref015]--[@pone.0121147.ref019]\] performed to examine the association between *MTHFR* 677C\>T polymorphism and the risk of male infertility, however, the results still inconsistent. Moreover, many new researches studied the association between male infertility risk and *MTHFR* 677C\>T after the last meta-analysis researching, so an updated and high quality meta-analysis is needed.

In order to evaluate the association between the *MTHFR* 677C\>T polymorphism and male infertility risk, we carried out a meta-analysis with subgroup analysis using all the eligible published data until June 19, 2014.

Materials and Methods {#sec006}
=====================

Search Strategy and Selection Criteria {#sec007}
--------------------------------------

According to the Meta-analysis on Genetic Association Studies Checklist ([S1 Checklist](#pone.0121147.s001){ref-type="supplementary-material"}), we conducted a computer-based systematic search of PubMed, EMBASE, Google Scholar and China National Knowledge Infrastructure (CNKI) without restriction on language (updated to June 19, 2014). The key words were as follows: ''methylenetetrahydrofolate reductase" or "*MTHFR*", ''polymorphism" or ''variant", "infertility" or ''azoospermia" or "oligoasthenoteratozoospermia" or ''oligozoospermia" or "subinfertility". In addition, we checked the references of all eligible articles which our research retrieved. For the meta-analysis, the following inclusion criteria were considered: (1) studied on human beings; (2) studies which evaluated the association between *MTHFR* 677C\>T polymorphism and male infertility risk; (3) studies with case-control design; (4) sufficient published data about the size of the sample, odds ratio (OR), and their 95% confidence interval (CI). For the exclusion criteria, we provided as follows: (1) without raw data for the calculation of odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs); (2) when studies with overlapping cases or controls, we included only the most recent or the largest report.

Data Extraction {#sec008}
---------------

According to the inclusion and exclusion criteria, the two investigators (Tingyu He and Zhirong Shi) extracted raw data independently in order to ensure the accuracy of extracted information. For conflicting evaluations, an agreement was reached following a discussion. The following information was collected from all eligible studies showing in [Table 1](#pone.0121147.t001){ref-type="table"}: the surname of the first author, date of publication, quality scores, ethnicity, sperm concentration subgroup categories, sources of controls, number of cases and controls and the *P* value of Hardy Weinberg Equilibrium (HWE). Different ethnic groups were mainly categorized as Caucasian, Asian and African. According to the sperm concentration, we divided the subgroup as azoospermia (Azoo), oligoasthenoteratozoospermia (OAT) and oligozoospermia (oligo) groups. Study designs were stratified to population-based studies and hospital-based studies.

10.1371/journal.pone.0121147.t001

###### Characteristics of eligible studies in the meta-analysis of *MTHFR* 677C\>T polymorphism and male infertility.

![](pone.0121147.t001){#pone.0121147.t001g}

                                              Cases                     Controls                    
  ------------------- ------ --- ------- ---- ------- ----- ----- ----- ---------- ----- ----- ---- -------
  **Asians**                                                                                        
      Park            2005   6   Total   HB   373     105   205   63    396        145   200   51   0.161
                                 Azoo         286     75    164   47                                
                                 OAT          85      28    40    17                                
      Lee             2006   6   Total   HB   360     115   181   64    325        118   166   41   0.138
                                 Azoo         174     44    100   30                                
                                 OAT          186     71    81    34                                
      A               2007   6   Total   NA   355     130   160   65    252        128   95    29   0.085
                                 Azoo         228     83    97    48                                
                                 oligo        127     47    63    17                                
      Sun             2007   5   Total   PB   182     27    86    69    53         15    28    10   0.630
                                 OAT          22      3     11    8                                 
                                 oligo        46      10    20    16                                
      Yang            2010   5   Total   PB   131     34    55    42    293        98    142   53   0.901
      Qiu             2011   6   Total   NA   271     75    112   84    180        63    85    32   0.720
                                 Azoo         158     42    66    50                                
                                 oligo        113     33    46    34                                
      Safarinejad     2011   6   OAT     HB   164     58    80    26    328        144   148   36   0.825
      Liu             2012   7   Total   PB   75      27    38    10    72         40    28    4    0.753
      Pei             2013   7   Total   PB   290     39    138   113   90         24    47    19   0.651
      Li              2014   6   Total   HB   82      14    36    32    133        36    61    36   0.340
  **Caucasians**                                                                                    
      Ebisch          2003   7   Total   PB   77      42    28    7     113        50    48    15   0.522
      Stuppia         2003   5   Total   NA   93      37    37    19    105        33    43    29   0.065
                                 Azoo         21      8     6     7                                 
                                 oligo        66      25    29    12                                
      Singh           2005   6   Total   PB   151     105   40    6     200        163   37    0    0.149
      Paracchini      2006   6   Total   PB   59      11    32    16    46         18    21    7    0.830
      Ravel           2009   6   Total   HB   250     118   101   31    114        49    52    13   0.887
                                 Azoo         70      33    31    6                                 
                                 oligo        180     85    70    25                                
      Murphy          2011   7   Total   PB   149     73    63    13    182        94    73    15   0.876
      Gupta           2011   5   Total   HB   522     378   116   28    315        251   58    6    0.228
                                 Azoo         68      49    15    4                                 
                                 OAT          65      41    23    1                                 
      Chellat         2012   5   Total   NA   74      31    33    10    84         36    38    10   0.995
                                 Azoo         46      20    19    7                                 
                                 OAT          28      11    14    3                                 
      Weiner          2013   6   Total   PB   271     129   116   26    301        153   115   33   0.112
                                 Azoo         98      49    41    8                                 
                                 oligo        82      40    31    11                                
      Naqvi           2014   5   Total   NA   637     447   154   36    364        275   79    10   0.145
                                 Azoo         49      34    11    4                                 
                                 OAT          65      39    24    2                                 
                                 oligo        37      23    12    2                                 
      Mfady           2014   6   Total   HB   150     67    63    20    150        74    67    9    0.221
  **Africans**                                                                                      
      Eloualid        2012   5   Total   NA   257     152   88    17    690        351   286   53   0.617
                                 Azoo         110     65    37    8                                 
                                 oligo        147     87    51    9                                 
  **Not mentioned**                                                                                 
      Gava (37)       2011   7   Total   PB   156     81    60    15    233        167   53    13   0.003
                                 Azoo         49      27    15    7                                 
                                 oligo        107     54    45    8                                 
      Gava (49)       2011   7   Total   PB   133     66    51    16    173        136   27    10   0.000
                                 Azoo         55      35    14    6                                 
                                 oligo        78      31    37    10                                
      Vani            2012   6   Total   HB   206     158   42    6     230        188   42    0    0.128
      Camprubí        2013   6   Total   PB   107     47    43    17    25         8     15    2    0.172
                                 oligo        23      12    9     2                                 

Azoo-azoospermia; OAT-oligoasthenoteratozoospermia; oligo-oligozoospermia

HB, hospital-based controls; PB, population-based controls

HWE, Hardy Weinberg Equilibrium

NA, not available

Quality assessment {#sec009}
------------------

Three authors (Guiying Huang, Rui Ren and Sichong Huang) assessed the study quality independently based on the Newcastle-Ottawa Scale \[[@pone.0121147.ref020]\], which uses a star rating system to judge the methodological quality. A full score is 9 stars, and a score range 5 to 9 stars is considered to be a generally high methodological quality while a score range 0 to 4 is considered to be a poor quality \[[@pone.0121147.ref021]\]. The quality of all included studies was summarized in [Table 2](#pone.0121147.t002){ref-type="table"}. Any disagreements on the NOS score of the studies were resolved through a comprehensive reassessment by the other authors and only high quality studies can be included in our meta-analysis.

10.1371/journal.pone.0121147.t002

###### Quality assessment based on the Newcastle-Ottawa Scale of studies included in this meta-analysis[^a^](#t002fn001){ref-type="table-fn"}.

![](pone.0121147.t002){#pone.0121147.t002g}

  First author   Year   Adequate definition of case   Representativeness of cases   Selection of control   Definition of control   Control for important factor or additional factor[^b^](#t002fn002){ref-type="table-fn"}   Exposure assessment   Same method of ascertainment for cases and controls   Nonresponse rate   Total quality scores
  -------------- ------ ----------------------------- ----------------------------- ---------------------- ----------------------- ----------------------------------------------------------------------------------------- --------------------- ----------------------------------------------------- ------------------ ----------------------
  Ebisch         2003   ★                             ★                             ★                      ★                       ★★                                                                                                              ★                                                                        7
  Stuppia        2003   ★                             ★                                                                            ★★                                                                                                              ★                                                                        5
  Park           2005   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Singh          2005   ★                             ★                             ★                                              ★★                                                                                                              ★                                                                        6
  Lee            2006   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Paracchini     2006   ★                             ★                             ★                      ★                                                                                                                 ★                     ★                                                                        6
  A              2007   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Sun            2007   ★                             ★                             ★                      ★                                                                                                                                       ★                                                                        5
  Ravel          2009   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Yang           2010   ★                             ★                             ★                      ★                                                                                                                                       ★                                                                        5
  Gava (37)      2011   ★                             ★                             ★                      ★                       ★★                                                                                                              ★                                                                        7
  Gava (49)      2011   ★                             ★                             ★                      ★                       ★★                                                                                                              ★                                                                        7
  Safarinejad    2011   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Murphy         2011   ★                             ★                             ★                      ★                       ★★                                                                                                              ★                                                                        7
  Qiu            2011   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Gupta          2011   ★                             ★                                                    ★                       ★                                                                                                               ★                                                                        5
  Eloualid       2012   ★                                                                                  ★                       ★★                                                                                                              ★                                                                        5
  Chellat        2012   ★                             ★                                                    ★                       ★                                                                                                               ★                                                                        5
  Vani           2012   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Liu            2012   ★                             ★                             ★                      ★                       ★★                                                                                                              ★                                                                        7
  Camprubí       2013   ★                             ★                             ★                      ★                       ★                                                                                                               ★                                                                        6
  Pei            2013   ★                             ★                             ★                      ★                       ★★                                                                                                              ★                                                                        7
  Weiner         2013   ★                             ★                             ★                                              ★★                                                                                                              ★                                                                        6
  Naqvi          2014   ★                             ★                                                    ★                       ★                                                                                                               ★                                                                        5
  Mfady          2014   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6
  Li             2014   ★                             ★                                                    ★                       ★★                                                                                                              ★                                                                        6

^a^A study can be awarded a maximum of one star for each numbered item except for the item Control for important factor or additional factor.

^b^A maximum of two stars can be awarded for Control for important factor or additional factor.

Statistical Analysis {#sec010}
--------------------

The association between *MTHFR* 677C\>T polymorphism and the male infertility risk were estimated by pooled ORs with 95% CI. The statistical significance of the pooled ORs was examined by *Z* test and *P* (two-tailed) \<0.05 was considered statistically significant. A chi-square test was used to examine the deviation from HWE for controls and *P* value\<0.05 signified a departure from HWE. In this meta-analysis, heterogeneity between studies was assessed by the *I* ^*2*^ test and which was considered statistically significant with *I* ^*2*^\>50% \[[@pone.0121147.ref022]\]. A fixed (the Mantel-Haenszel method) \[[@pone.0121147.ref023]\] or random effects model (the DerSimonian and Laird method) \[[@pone.0121147.ref024]\] was used to calculate pooled effect estimates in the absence (*I* ^*2*^≤50%) or presence (*I* ^*2*^\>50%) of heterogeneity, respectively. When heterogeneity between studies is absent, these two models provide similar results, if not, the random effects model is more appropriate. Subgroup analysis was performed by ethnicity, sperm concentration and the control sources. In addition, to assess the stability of results, sensitivity analysis was performed by omitting one study at a time and calculating the overall homogeneity and effect size. As publication bias was always concerned in meta-analysis, an evaluation of which was carried out with funnel plot and Egger's test (*P*\<0.05 was significant publication bias) \[[@pone.0121147.ref025]\]. The statistical analysis was performed with STATA statistical software (Version 12.0; Stata Corporation, College Station, TX, USA).

Results {#sec011}
=======

Study characteristics {#sec012}
---------------------

Through a literature searching, initially a total of 46 potentially relevant publications were indentified. Out of these, eleven studies were eliminated because they did not investigate the association between the *MTHFR* 677C\>T polymorphism and male infertility risk. After data extraction, we excluded 4 articles from the meta-analysis. One of them had no controls \[[@pone.0121147.ref026]\] while one of them had no cases \[[@pone.0121147.ref027]\], besides, the other two studies were excluded as one did not provide detailed information needed for OR calculation \[[@pone.0121147.ref028]\] while the last one did not directly research about the genotype and male infertility risk \[[@pone.0121147.ref029]\]. Hence, we obtained 31 relevant articles that examined the association between *MTHFR* 677C\>T and male infertility risk. Among of them, five studies were excluded because of the poor quality, which was evaluated by Newcastle-Ottawa Scale \[[@pone.0121147.ref030]--[@pone.0121147.ref034]\]. Therefore, only 26 studies qualifying our strict selection criteria were involved in the meta-analysis \[[@pone.0121147.ref011], [@pone.0121147.ref016], [@pone.0121147.ref019], [@pone.0121147.ref035]--[@pone.0121147.ref057]\] ([Fig. 1](#pone.0121147.g001){ref-type="fig"}). We established a database of the extracted information from each eligible article ([Table 1](#pone.0121147.t001){ref-type="table"}). The total data for this analysis included 5,575 cases and 5,447 controls for *MTHFR* 677C\>T polymorphism. All the researches contained in this meta-analysis are case-control studies. Of the 26 studies included in the meta-analysis, there were 10 studies of Asians, 11 studies of Caucasians, 1 study of African and 4 studies did not mention. According to the control sources, general populations were used as controls in 12 studies whereas hospital patients were used in 8 studies and 6 studies did not mention. The genotype distributions among the controls of all studies followed HWE except for two studies \[[@pone.0121147.ref037], [@pone.0121147.ref049]\].

![Flow diagram of study selection.](pone.0121147.g001){#pone.0121147.g001}

Overall analysis {#sec013}
----------------

*MTHFR* 677C\>T polymorphism showed significant associations with male infertility risk in both fixed effects (CT+TT vs. CC: OR = 1.34, 95% CI: 1.23--1.46, *P* = 0.000, *I* ^*2*^ = 68.2%; TT vs. CT+CC: OR = 1.60, 95% CI: 1.41--1.81, *P* = 0.000, *I* ^*2*^ = 36.9%; TT vs. CC: OR = 1.76, 95% CI: 1.53--2.01, *P* = 0.000, *I* ^*2*^ = 54.0%; T vs. C: OR = 1.32, 95% CI: 1.24--1.41, *P* = 0.000, *I* ^*2*^ = 71.5%) and random effects models (CT+TT vs. CC: OR = 1.39, 95% CI: 1.19--1.62, *P* = 0.000, *I* ^*2*^ = 68.2%, [Fig. 2A](#pone.0121147.g002){ref-type="fig"}; TT vs. CT+CC: OR = 1.58, 95% CI: 1.34--1.88, *P* = 0.000, *I* ^*2*^ = 36.9%; TT vs. CC: OR = 1.80, 95% CI: 1.44--2.24, *P* = 0.000, *I* ^*2*^ = 54.0%; T vs. C: OR = 1.36, 95% CI: 1.20--1.53, *P* = 0.000, *I* ^*2*^ = 71.5%).

![Forest plots of *MTHFR* 677C\>T polymorphism and male infertility risk (CT+TT vs. CC).\
\[**A** for overall populations; **B** for ethnicity subgroup; **C** for sperm concentration subgroup; **D** for control sources subgroup\]. The squares and horizontal lines correspond to the study-specific OR and 95% CI. The area of the squares reflects the study-specific weight (inverse of the variance). Diamonds represent the pooled OR and 95% CI. ^a^the 37^th^ reference, ^b^the 49^th^ reference](pone.0121147.g002){#pone.0121147.g002}

Ethnic origin {#sec014}
-------------

When stratified by ethnicity, the same associations between the *MTHFR* 677C\>T polymorphism and male infertility were found in Asians (CT+TT vs. CC: fixed effects model, OR = 1.54, 95% CI: 1.35--1.76, *P* = 0.000, *I* ^*2*^ = 0.0%) and Caucasians (CT+TT vs. CC: fixed effects model, OR = 1.19, 95% CI: 1.05--1.36, *P* = 0.007, *I* ^*2*^ = 48.1%, [Fig. 2B](#pone.0121147.g002){ref-type="fig"}).

Sperm concentration subgroup {#sec015}
----------------------------

Subgroup analyses were also performed for azoospermia (Azoo), oligoasthenoteratozoospermia (OAT) and oligozoospermia (oligo) groups ([Fig. 2C](#pone.0121147.g002){ref-type="fig"}). Studies without the genotype frequencies for these subgroups were excluded. Finally, the total number of cases and controls for Azoo, OAT and oligo were 1,412 and 3,532, 615 and 1,865, 1,006 and 2,490, respectively. The results showed enhanced risks of male infertility with the *MTHFR* 677C\>T were acquired both in Azoo (CT+TT vs. CC: fixed effects model, OR = 1.36, 95% CI: 1.18--1.55, *P* = 0.000, *I* ^*2*^ = 49.1%) and OAT (CT+TT vs. CC: fixed effects model, OR = 1.35, 95% CI: 1.11--1.64, *P* = 0.003, *I* ^*2*^ = 44.7%) subgroups. Whereas, no significant association was observed in oligo subgroup (CT+TT vs. CC: random effects model, OR = 1.34, 95% CI: 0.91--1.98, *P* = 0.138, *I* ^*2*^ = 81.7%).

Control sources {#sec016}
---------------

When considered the sources of the control groups, five studies were excluded for unclear source of controls. Dramatically elevated risks were found both in population-based (CT+TT vs. CC: random effects model, OR = 1.66, 95% CI: 1.23--2.23, *P* = 0.001, *I* ^*2*^ = 72.5%) and hospital-based controls (CT+TT vs. CC: fixed effects model, OR = 1.32, 95% CI: 1.15--1.52, *P* = 0.000, *I* ^*2*^ = 0.0%) ([Fig. 2D](#pone.0121147.g002){ref-type="fig"}).

Sensitivity analyses {#sec017}
--------------------

To assess the effect of individual study on all subjects and subgroups, the sensitivity analyses were performed by excluding one study each time. If the exclusion of any single study did not alter the significance of the final decision, it suggested that the outcomes were robust. However, our corresponding pooled ORs were not materially altered in all subjects and all subgroups. In addition, when excluding the two studies \[[@pone.0121147.ref037], [@pone.0121147.ref049]\] which did not follow HWE, the pooled ORs for all subjects still did not change remarkably (data not shown). Therefore, the results of sensitivity analyses confirmed the stability for our results in this meta-analysis.

Publication bias {#sec018}
----------------

For the diagnosis of publication bias, both Begg's Funnel plot and Egger's test were performed in this meta-analysis. The shape of the funnel plot was symmetrical and the *P* value of Egger's test also suggested that there was no evidence of publication bias (*P* = 0.339; [Fig. 3](#pone.0121147.g003){ref-type="fig"}).

![Funnel plot for publication bias of *MTHFR* 677C\>T and infertility risk (CT+TT vs. CC) in overall populations.\
The horizontal line in the funnel plot indicates the random-effects summary estimate. Sloping lines indicate the expected 95% CI for a given SE.](pone.0121147.g003){#pone.0121147.g003}

Discussion {#sec019}
==========

Male infertility is a heterogeneous disease, with various genetic and environmental factors contributing to the impairment of spermatogenesis. Spermatogenesis is a complex process that governed by a tightly controlled series of gene expression events \[[@pone.0121147.ref058]\] and is associated with folate metabolism \[[@pone.0121147.ref059]--[@pone.0121147.ref061]\]. A possible candidate gene for genetic susceptibility to spermatogenic failure is *MTHFR*. *MTHFR* is an important regulatory enzyme in folate metabolism, DNA synthesis and remethylation reactions \[[@pone.0121147.ref062], [@pone.0121147.ref063]\]. It is suggested that the *MTHFR* might play an important role in spermatogenesis because of its higher activity in testes than in other major organs in the adult mouse \[[@pone.0121147.ref064]\]. In 2001, Bezold et al. \[[@pone.0121147.ref031]\] first reported the association between *MTHFR* 677C\>T mutation and the male infertility risk. Subsequently, many epidemiological studies have been addressed to investigate the association between *MTHFR* 677C\>T polymorphism and the risk of male infertility during the past decades, but the findings were inconsistent. Consequently, five meta-analyses \[[@pone.0121147.ref015]--[@pone.0121147.ref019]\] were conducted to exam the association between male infertility risk and the *MTHFR* 677C\>T polymorphism, however, the results of them were controversial. In addition, the data of last meta-analysis \[[@pone.0121147.ref019]\] was updated two years ago (Apr. 2012). During these two years, many studies investigated the association between the *MTHFR* 677C\>T polymorphism and male infertility risk were published. Therefore, in order to derive a powerful estimate of the male infertility risk associated with the *MTHFR* 677C\>T polymorphism, we carried out the present meta-analysis.

The present meta-analysis, including 5,575 cases and 5,447 controls from 26 published studies, explored the association between the *MTHFR* 677C\>T polymorphism and male infertility risk. The numbers of contained studies, the cases and controls in this meta-analysis are much more than the prior five meta-analyses. In addition, we did the quality assessment for the studies by Newcastle-Ottawa Scale while all the former meta-analyses did not do. Only the study had good quality of which score was more than 5 stars, then it could be included in the meta-analysis. Hence, our study made a more detailed and convincible evaluation than all the prior meta-analyses did. Overall, we find the *MTHFR* 677C\>T variant genotype were significantly associated with male infertility risk based on both fixed effects and random effects models, and which was consistent with the results of Tüttelmann et al. \[[@pone.0121147.ref015]\], Gupta et al. \[[@pone.0121147.ref016]\] and Wu et al. \[[@pone.0121147.ref017]\], but inconsistent with the results of Wei et al. \[[@pone.0121147.ref018]\] and Weiner et al. \[[@pone.0121147.ref019]\]. All the characteristics and results of the present study compared with the former five meta-analyses were summarized in [Table 3](#pone.0121147.t003){ref-type="table"}.

10.1371/journal.pone.0121147.t003

###### Characteristics and results of the present study compared with the former five meta-analyses.
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  First author        Year of publication   Time of data updated   No. of studies   No. of cases   No. of controls   Quality assessment   Overall results   Asians   Caucasians   Azoo   OAT   Oligo   PB   HB
  ------------------- --------------------- ---------------------- ---------------- -------------- ----------------- -------------------- ----------------- -------- ------------ ------ ----- ------- ---- ----
  Tüttelmann F        2007                  NA                     8                1843           1791              No                   \+                NA       NA           NA     NA    NA      NA   NA
  Gupta N             2011                  Mar. 2011              14               3094           2877              No                   \+                NA       NA           \+     −     \+      NA   NA
  Wu W                2012                  Sep. 2010              9                2275           1958              No                   \+                \+       −            \+     −     NA      NA   NA
  Wei B               2012                  Jan. 2011              11               2217           2312              No                   −                 \+       −            NA     NA    NA      NA   NA
  Weiner AS           2014                  Apr. 2012              13               2972           3436              No                   −                 NA       NA           −      NA    −       NA   NA
  The present study   NA                    Jun. 2014              26               5575           5447              Yes                  \+                \+       \+           \+     \+    −       \+   \+

Azoo-azoospermia; OAT-oligoasthenoteratozoospermia; Oligo-oligozoospermia

HB, hospital-based controls; PB, population-based controls

+, positive result

−, negative result

NA, not available

As heterogeneity for *MTHFR* 677C\>T polymorphism among all the studies was significant, we conducted the subgroup analyses. When stratified by ethnicity, our results indicated that significant male infertility risks of people with *MTHFR* 677C\>T polymorphism both in Asians and Caucasians. We are the first one that reported significant association between *MTHFR* 677C\>T polymorphism and male infertility in Caucasians. Moreover, the heterogeneity was effectively decreased or removed after subgroup analyses by ethnicity. Therefore, as the differences of genetic backgrounds among different populations, one main reason for heterogeneity in this meta-analysis may be the ethnicity.

According to the sperm concentration, we found remarkable associations between Azoo or OAT subgroup and *MTHFR* 677C\>T polymorphism in the present study. While, no strong association was observed in oligo subgroup. Compared with the former meta-analyses, we are the first one reported the *MTHFR* 677C\>T polymorphism has a dramatically increased risk in male infertility susceptibility in OAT subgroup and the sensitivity analysis showed the stabilization of this result. However, as the extreme heterogeneity existed in oligo subgroup, the result of it may be less powerful and we should treat it carefully. Further studies based on oligo and *MTHFR* 677C\>T are necessary to confirm the association.

In addition, when stratified by the sources of the control groups, our results showed that the *MTHFR* 677C\>T polymorphism were dramatic associated with male infertility risk both in population-based and hospital-based controls. At present, it is reported that the *MTHFR* 677C\>T polymorphism could influence the susceptibility to some common diseases, such as type 2 diabetes \[[@pone.0121147.ref065]\], coronary heart disease \[[@pone.0121147.ref066]\] and colorectal cancer, et al. \[[@pone.0121147.ref067]\]. Thus, the data on hospital-based controls may have a high risk of inducing unreliable result because it may not always represent the general population indeed, especially when the genotype under investigation are expected to affect other diseases. However, we obtained consistent results between population-based and hospital-based controls.

In recent years, the application of the genome-wide association study (GWAS) in many types of diseases has exploded. Until now, there are twelve GWASs about male infertility, and two of them \[[@pone.0121147.ref068], [@pone.0121147.ref069]\] mentioned the *MTHFR* 677C\>T polymorphism. However, concerned with the male infertility and *MTHFR* 677C\>T polymorphism, the results of these two GWASs were inconsistent with our meta-analysis. The reasons of this phenomenon are possibly as follows: (1) These two GWASs both conducted by Aston KI only included Caucasians of European decent, while we included men of other ethnicities. SNP frequencies vary widely between ethnic groups, for example, the frequency of the *MTHFR* 677C\>T allele varies significantly among populations, ranging from 30% to 40% in Europe and America to 5% to 10% in Africa and Sri Lanka \[[@pone.0121147.ref070], [@pone.0121147.ref071]\]; (2) The small sample size both of these two GWASs (Aston et al., 2009: 80 controls, 92 cases; Aston et al., 2010: 158 controls, 282 cases) limited the interpretation of the results. However, a large portion of the heritability of complex diseases has not been well explained by GWASs \[[@pone.0121147.ref072]\]. About missing heritability, one plausible explanation may be the loss of low-frequency variants, which are not well captured by current genotyping arrays \[[@pone.0121147.ref073]\]. Another explanation is that the common variants of small effect sizes, do not reach the thresholds of genome wide significance in GWASs \[[@pone.0121147.ref074]\].

Although several previous meta-analyses have researched the association between male infertility risk and *MTHFR* 677C\>T polymorphism, our study was more rigorous and comprehensive. First, more up-to-date studies (26 studies) that contained a substantial number of cases and controls were pooled from published studies, which dramatically increased the statistical power of the analysis. Second, the quality of studies included in this meta-analysis was satisfactory, as we first used the Newcastle-Ottawa Scale to assess the quality of the articles. When the study met our strict criteria, it could be enrolled in. Third, we are the first that showed the significantly increased risk between *MTHFR* 677C\>T polymorphism and male infertility in Caucasians and OAT subgroup. Also, for the first time we performed in detail to check into the association between male infertility risk and *MTHFR* 677C\>T polymorphism according to the control sources. Our results showed obvious higher male infertility risk in both population-based and hospital-based controls.

Nonetheless, there are some limitations should be addressed in this meta-analysis. First of all, the heterogeneities for *MTHFR* 677C\>T polymorphism among all the studies was dramatic. Even though we conducted subgroup analyses and the heterogeneity was efficiently decreased or removed in some subgroups, it still existed in the population-based controls and oligo subgroup. Several reasons could explain the significant heterogeneity. First, lifestyle factors especially intake of folate and B-vitamins may play a role. For instance, deficient intake of folate and vitamin B12 is prevalent in India \[[@pone.0121147.ref075]--[@pone.0121147.ref077]\]; in contrast, sufficient intake of folate is prevalent in France \[[@pone.0121147.ref078]\], Korea \[[@pone.0121147.ref011]\] and Italy \[[@pone.0121147.ref079]\]. Second, due to the various genotyping methods used in the studies, the genotyping error is hard to avoid. However, when we eliminated the studies which did not follow the HWE, our results did not change statistically. Third, it has been shown that there were other underlying confounding factors in the included studies, such as gene-environment interaction, or selection bias, or chance \[[@pone.0121147.ref080], [@pone.0121147.ref081]\]. Although evidence of heterogeneity exists, our overall results used by fixed effects models were consistent with which used by random effects models. Moreover, the sensitivity analyses results showed that all of our results were stable and certain. Secondly, as the use of unadjusted data, some potential confounding factors, such as age, sex and residence might slightly modify the effective estimates. Hence, a more precise evaluation according to the adjusted data is needed. Finally, as only published studies were retrieved in the present meta-analysis, the selection bias may have occurred, even though the funnel plot and Egger's test have not shown publication bias. Also, the number of published studies was not large enough for a comprehensive analysis, particularly for some subgroups.

Conclusions {#sec020}
===========

In summary, our meta-analysis suggested that the *MTHFR* 677C\>T polymorphism is associated with an enhanced risk of male infertility, supporting the hypothesis that the *MTHFR* 677C\>T may be a potential cause of male infertility. Specifically, increased infertility risks with *MTHFR* 677C\>T were observed in overall analysis and most subgroups, except oligo subgroup. However, large scale, well-designed and high quality epidemiological studies will be required to confirm our findings in the future.
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